Fujian South Pharmaceutical Co, Ltd. (hereinafter referred to as FSP), was founded in2001, located in Sanming City, Fujian, China. FSP is a GMP pharmaceutical company with a wide range of activities including taxus planting, R&D, production and sales.
API represented by Paclitaxel and Docetaxel covers market like Russia, EU, India, Brazil, Argentina, Turkey, Korea, etc. FSP has passed the site inspections conducted by NMPA, EDOM, FDA and COFEPRIS.